Navigation Links
CellHealth Institute is Named 2013 Edison Award Winner
Date:5/9/2013

MONTCLAIR, N.J. (PRWEB) May 09, 2013

CellHealth™ Institute was voted a bronze winner for innovation at the Edison Awards. The event, celebrating 26 years of honoring the best in innovation and excellence in the development of new products and services, took place on April 25th event at Navy Pier in Chicago. Dr. Vincent Giampapa, CellHealth Institute’s founder and chief medical officer, joined hundreds of senior executives from some of the world’s most recognized companies to acknowledge the hard work and commitment of all of the 2013 Edison Award winners.

CellHealth Institute, a biotechnology company focused on cellular health that combines products and services with holistic lifestyle education, was awarded for its innovative health and wellness services. Dr. Vincent Giampapa also spoke about personalized cell health and CHI’s new cell health formula, everycell™, at the ‘Meet The Innovators’ Forum.

“We’re delighted that our innovations in cell health are gaining strong support in such illustrious circles,” said Dr. Vincent Giampapa.

“Our judges recognized CellHealth Institute as a true innovator out of the many products in health and wellness,” said Frank Bonafilia, executive director of the Edison Awards.

The ballot of nominees for the Edison Awards™ was judged by a panel of more than 3,000 leading business executives including past award winners, academics and leaders in the fields of product development, design, engineering, science and medical.

One of the evening’s many highlights was the presentation of the Edison Achievement Award to Dr. Paul E. Jacobs, chairman and CEO of Qualcomm Incorporated. The award honors innovation leaders and business executives who have made a significant and lasting contribution to innovation throughout their careers.

About CellHealth™ Institute
CellHealth Institute (CHI) is a biotechnology company focused on cellular health that integrates breakthrough products and services with holistic lifestyle education. CHI collaborates with top-tier research universities and publicly traded biotech companies to offer fully integrated personalized health programs paired with scientific biomarker evaluations, as well as medical-grade supplements, including everycell™, and advanced treatment through stem cell therapies. The organization is headquartered in New Jersey with an international regenerative medicine destination in Costa Rica set to open in 2014. CHI services and products allow people to take control of their own health at the most basic level – their cells.

Read the full story at http://www.prweb.com/releases/2013/5/prweb10716610.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. CellHealth Institute Launches New Cell Health Formula
2. CellHealth Institute Launches with Support from Influential Investors
3. Veterinary Bioscience Institute Responds to Demand by Bringing Back Their Most Popular Webinar Series
4. Lorain County Community College, Austen BioInnovation Institute Join to Advance Medical Technologies
5. Real Time Genomics and J. Craig Venter Institute Embark on Strategic Research Initiative
6. Averica Discovery Services and Worcester Polytechnic Institute Establish Research Collaboration
7. Stem Cell Institute Public Seminar on Adult Stem Cell Therapy in Miami, Florida May 11th, 2013
8. Jennifer C. Smith, DVM DACLAM, Formerly of Taconic Farms, Inc. Joins the Veterinary Bioscience Institute as the Vice President of Research and Development
9. Scripps Research Institute Scientists Find Antibody that Transforms Bone Marrow Stem Cells Directly into Brain Cells
10. California Healthcare Institute Announces Executive Promotion
11. Dr. J. Robert Beyster and Betty J. Beyster Make $2.5 Million Pledge to the J. Craig Venter Institute
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Brooklyn, NY (PRWEB) , ... June 24, 2016 , ... ... 15mm, machines such as the Cary 5000 and the 6000i models are higher end ... height is the height of the spectrophotometer’s light beam from the bottom of the ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
(Date:6/23/2016)... 2016  The Biodesign Challenge (BDC), a university competition ... harness living systems and biotechnology, announced its winning teams ... New York City . The ... projects at MoMA,s Celeste Bartos Theater during the daylong ... senior curator of architecture and design, and Suzanne ...
(Date:6/23/2016)... Apellis Pharmaceuticals, Inc. today announced positive ... its complement C3 inhibitor, APL-2. The trials were ... studies designed to assess the safety, tolerability, pharmacokinetics ... healthy adult volunteers. Forty subjects were ... dose (ranging from 45 to 1,440mg) or repeated ...
Breaking Biology Technology:
(Date:3/31/2016)... , March 31, 2016   ... ("LegacyXChange" or the "Company") LegacyXChange is excited ... of its soon to be launched online site for ... https://www.youtube.com/channel/UCyTLBzmZogV1y2D6bDkBX5g ) will also provide potential shareholders a ... DNA technology to an industry that is notorious for ...
(Date:3/29/2016)... 29, 2016 LegacyXChange, Inc. (OTC: ... and SelectaDNA/CSI Protect are pleased to announce our successful ... a variety of writing instruments, ensuring athletes signatures against ... collectibles from athletes on LegacyXChange will be assured of ... DNA. Bill Bollander , CEO states, ...
(Date:3/22/2016)... India , March 22, 2016 /PRNewswire/ ... market research report "Electronic Sensors Market for Consumer ... Proximity, & Others), Application (Communication & IT, ... Geography - Global Forecast to 2022", published ... industry is expected to reach USD 26.76 ...
Breaking Biology News(10 mins):